Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study
- PMID: 23496906
- PMCID: PMC3599351
- DOI: 10.1186/1477-9560-11-6
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study
Abstract
Background: While the assessment of analytical precision within medical laboratories has received much attention in scientific enquiry, the degree of as well as the sources causing variation between them remains incompletely understood. In this study, we quantified the variance components when performing coagulation tests with identical analytical platforms in different laboratories and computed intraclass correlations coefficients (ICC) for each coagulation test.
Methods: Data from eight laboratories measuring fibrinogen twice in twenty healthy subjects with one out of 3 different platforms and single measurements of prothrombin time (PT), and coagulation factors II, V, VII, VIII, IX, X, XI and XIII were analysed. By platform, the variance components of (i) the subjects, (ii) the laboratory and the technician and (iii) the total variance were obtained for fibrinogen as well as (i) and (iii) for the remaining factors using ANOVA.
Results: The variability for fibrinogen measurements within a laboratory ranged from 0.02 to 0.04, the variability between laboratories ranged from 0.006 to 0.097. The ICC for fibrinogen ranged from 0.37 to 0.66 and from 0.19 to 0.80 for PT between the platforms. For the remaining factors the ICC's ranged from 0.04 (FII) to 0.93 (FVIII).
Conclusions: Variance components that could be attributed to technicians or laboratory procedures were substantial, led to disappointingly low intraclass correlation coefficients for several factors and were pronounced for some of the platforms. Our findings call for sustained efforts to raise the level of standardization of structures and procedures involved in the quantification of coagulation factors.
Similar articles
-
[Standardization Committee for Haematology. External Quality Assurance Program for General Hematology. Evaluation of the 1994 results].Sangre (Barc). 1996 Apr;41(2):115-23. Sangre (Barc). 1996. PMID: 9045351 Spanish.
-
Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).Clin Chem Lab Med. 2019 Sep 25;57(10):1511-1521. doi: 10.1515/cclm-2019-0214. Clin Chem Lab Med. 2019. PMID: 31085743
-
Effects on coagulation factor production following primary hepatomitogen-induced direct hyperplasia.World J Gastroenterol. 2009 Nov 14;15(42):5307-15. doi: 10.3748/wjg.15.5307. World J Gastroenterol. 2009. PMID: 19908339 Free PMC article.
-
Coagulation Testing in the Core Laboratory.Lab Med. 2017 Nov 8;48(4):295-313. doi: 10.1093/labmed/lmx050. Lab Med. 2017. PMID: 29126301 Review.
-
Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.Biochem Med (Zagreb). 2019 Jun 15;29(2):020503. doi: 10.11613/BM.2019.020503. Biochem Med (Zagreb). 2019. PMID: 31223257 Free PMC article. Review.
Cited by
-
The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.Blood Adv. 2018 Aug 28;2(16):2136-2144. doi: 10.1182/bloodadvances.2018020552. Blood Adv. 2018. PMID: 30143528 Free PMC article. Clinical Trial.
-
Measurement of rivaroxaban and apixaban in serum samples of patients.Eur J Clin Invest. 2014 Aug;44(8):743-52. doi: 10.1111/eci.12291. Eur J Clin Invest. 2014. PMID: 24931429 Free PMC article.
-
The factor VIII treatment history of non-severe hemophilia A.J Thromb Haemost. 2020 Dec;18(12):3203-3210. doi: 10.1111/jth.15076. Epub 2020 Sep 28. J Thromb Haemost. 2020. PMID: 32877570 Free PMC article.
-
[Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units].Anaesthesist. 2021 Aug;70(8):662-670. doi: 10.1007/s00101-021-00916-9. Epub 2021 Feb 8. Anaesthesist. 2021. PMID: 33558944 Free PMC article. German.
-
[Practice of pharmaceutical thrombosis prophylaxis and anticoagulation in patients with sepsis and pre-existing anticoagulation or heparin-induced type II thrombocytopenia-Results of a nationwide survey in German intensive care units].Anaesthesist. 2022 Mar;71(3):193-200. doi: 10.1007/s00101-021-01011-9. Epub 2021 Aug 5. Anaesthesist. 2022. PMID: 34351433 Free PMC article. German.
References
-
- Marshall WJ, Bangert SK, Lapsley M. Clinical Chemistry. Philadelphia, PA: Mosby Elsevier; 2012. The clinical utility of laboratory investigations; p. 9. volume 7.
-
- NCCLS. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. Wayne, PA: NCCLS; 1999.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous